Research shows weight-loss drugs may also reduce cancer risk
Summary
Research shows that some weight-loss drugs, such as Ozempic and Wegovy, might also help lower the risk of certain types of cancer. These drugs, known as GLP-1s, are used by many adults in the United States.Key Facts
- Ozempic and Wegovy are weight-loss drugs that belong to a group called GLP-1s.
- GLP-1 drugs are currently taken by about one in every eight adults in the U.S.
- New studies suggest these drugs may help prevent or treat some cancers.
- The discovery of this benefit is recent and still being studied.
- Scientists are exploring how these drugs could affect cancer risk.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.